glibentek (glibenclamide oral suspension) April 12, 2017 glibentek (glibenclamide oral suspension) Trade Name Orphan Indication Neonatal diabetes (monogenic forms of diabetes that present in infancy) USA Market Approval USA USA Designation Date 2016-06-08 00:00:00 Sponsor AMMTeK;15 Rue B�ranger;Paris